GNRSU The Greenrose Holding Co. (PNK) collapses to $0.000001 on 06 Feb 2026: assess solvency

The GNRSU stock plunged intraday to $0.000001 on 06 Feb 2026 during market hours, a collapse from yesterday’s $0.15 close and a -99.99933% move. Trading volume was light at 145 shares, while market cap sits at $13.00 on the PNK exchange in the United States. We review what drove the drop, the company’s key ratios, and what traders should watch next for The Greenrose Holding Company Inc.

GNRSU stock: Intraday collapse and price action

GNRSU stock moved from a previous close of $0.15 to an intraday $0.000001, a day change of -0.149999 or -99.99933%. Volume was 145 shares, far below typical levels for liquid names, which magnifies price moves and increases volatility. The tiny market cap of $13.00 on PNK and limited trading suggest price swings reflect very low liquidity rather than updated long-term fundamentals.

Valuation and key financials for The Greenrose Holding Company Inc.

The company reports EPS of 3.10 and a notional P/E near 0.00 given the micro share price; reported PE in raw data is extremely small. Book value per share is 4.30 and cash per share is 0.56, while shares outstanding are 12,853,627. Working capital is deeply negative at -103,434,000.00, and enterprise value metrics appear distorted by the tiny quoted price but show high leverage relative to market cap.

Sector context and GNRSU analysis versus peers

Greenrose operates in Healthcare, specifically Drug Manufacturers – Specialty & Generic and the cannabis sector. Sector investors have tightened risk tolerance and larger cannabis peers show higher volume and clearer fundamentals. Compared to peers, GNRSU’s trading range (year high $0.151, year low $0.000001) and thin liquidity place it at the high end of microcap volatility and trading risk.

Meyka AI grade and technical/risks summary

Meyka AI rates GNRSU with a score out of 100: 67.07 | Grade: B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Key risks include extreme liquidity constraints, negative working capital, and large swings in quoted price. Key strengths include positive reported EPS and book value per share, but those metrics are hard to rely on when market cap is near zero.

Trading signals, catalysts and what to watch in GNRSU stock

Monitor press releases, SEC filings, or corporate communications from The Greenrose Holding Company Inc. for any share restructurings, reverse splits, or delist risk. Watch volume spikes above 1,000 shares and price action relative to the year high $0.151. For short-term traders, watch liquidity and spreads; for investors, focus on audited financial disclosures and potential corporate actions that change share count or marketability.

Meyka AI forecast and price target for GNRSU

Meyka AI’s forecast model projects a 12‑month reference price of $0.05 for GNRSU, assuming resolution of liquidity constraints and positive corporate news. Against the current quote of $0.000001, that implies an implied upside of approximately 4,999,900.00%. Forecasts are model‑based projections and not guarantees; they assume marketability improves and do not account for delisting or dilution events.

Final Thoughts

Key takeaways for GNRSU stock: the intraday quote of $0.000001 on 06 Feb 2026 reflects extreme illiquidity rather than a clean valuation reset. Fundamental metrics show EPS 3.10 and book value per share 4.30, but negative working capital (-103,434,000.00) and a market cap of $13.00 on PNK create material execution and solvency questions. Meyka AI’s forecast model projects a 12‑month price of $0.05, which implies a theoretical upside of 4,999,900.00% versus the current quote; this is a model output and not a guarantee. Traders should treat GNRSU as a high‑risk microcap: expect wide spreads, potential delisting or corporate actions, and limited liquidity. For more up‑to‑date filings and company announcements see the company site Greenrose Holdings and our GNRSU page on Meyka AI for live updates and alternative data signals. Meyka AI is an AI‑powered market analysis platform and provides model-based grades and forecasts to help frame risk, not investment advice.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.